 SEATTLE, WA and VANCOUVER, BC ACCESSWIRE August 11, 2021 Achieve Life Sciences, Inc. NASDAQ:ACHV, a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that the United States Patent and Trademark Office USPTO has issued U.S. Patent No. 11,083,715 and U.S. Patent No. 